Vinca-alkaloid vesicles with enhanced efficacy and tumor targeti

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9127, A61K 9133

Patent

active

061208000

ABSTRACT:
A liposome formulation containing a Vinca Alkaloid and an anion in an aqueous phase of the liposome. The liposomes also comprise distearoylphosphatidyl choline, cholesterol and disteraroylphosphatidylglycerol. A method for enhancing the efficacy and tumor targeting properties of liposomal vinca alkaloid formulations containing unilamellar vesicles.

REFERENCES:
patent: 4769250 (1988-09-01), Forssen
patent: 4963363 (1990-10-01), Forssen
patent: 5019369 (1991-05-01), Presant et al.
patent: 5080904 (1992-01-01), Iga et al.
patent: 5316771 (1994-05-01), Barenholz et al.
patent: 5456916 (1995-10-01), Kurata et al.
patent: 5714163 (1998-02-01), Forssen
patent: 5888537 (1999-03-01), Forssen
Boman et al. (1993) Biochimica et Biophysica Acta 1152:253.
Boman et al. (1994) Cancer Research 54:2830.
Forssen et al. (1993) Proc. Am. Assoc. Cancer Res. 34:365.
Layton and Trouet (1980) 16:945.
Mayer et al. (1993) Cancer Chemother. Pharmacol. 33:17.
Vaage et al. (1993) Int. J. Cancer 54:959.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Vinca-alkaloid vesicles with enhanced efficacy and tumor targeti does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vinca-alkaloid vesicles with enhanced efficacy and tumor targeti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vinca-alkaloid vesicles with enhanced efficacy and tumor targeti will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1069648

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.